A 9-Week Nordic and Free Walking Improve Postural Balance in Parkinson’s Disease

. 2018 Jan 8;2(2):E28–E34. doi: 10.1055/s-0043-124757

Table 2 Mean (95% confidence interval) values from center of pressure parameters.

Variable	Group	Eyes closed		Eyes open
		T1	T2	T1	T2
		Mean±SE	Mean±SE	Mean±SE	Mean±SE
AV (mm.s ^-1 )	FW	27.12 (20.25 to 33.99)	39.48 (27.13 to 51.83)	19.56 (15.18 to 23.93)	35.41 (26.51 to 44.32)
AV (mm.s ^-1 )	NW	38.48 (25.47 to 51.49)	48.29 (31.56 to 65.01)	26.64 (16.65 to 32.63)	31.78 (20.67 to 42.90)
RMS AP (mm)	FW	7.15 (5.82 to 8.47) ^a,A	11.75 (8.56 to 14.93) ^a,B	6.54 (4.80 to 8.27) ^a,A	10.47 (7.79 to 13.14) ^a,B
RMS AP (mm)	NW	8.31 (6.49 to 10.12) ^a,A	14.94 (11.78 to 18.09) ^a,B	7.34 (5.32 to 9.34) ^a,A	13.25 (10.97 to 15.53) ^a,B
RMS ML (mm)	FW	6.50 (4.34 to 8.65) ^a,A	10.79 (8.07 to 13.51) ^a,B	5.52 (4.21 to 6.83) ^a,A	9.91 (7.19 to 12.62) ^a,B
RMS ML (mm)	NW	7.47 (6.27 to 8.67) ^a,A	10.74 (7.58 to 13.89) ^a,B	6.15 (4.88 to 7.42) ^a,A	8.35 (6.13 to 10.57) ^a,B
ADA AP (mm)	FW	38.24 (30.11 to 46.38) ^a,A	57.93 (41.48 to 74.38) ^a,B	32.46 (24.61 to 40.31) ^a,A	56.12 (38.93 to 73.31) ^a,B
ADA AP (mm)	NW	41.81 (33.75 to 49.86) ^a,A	73.57 (55.90 to 91.24) ^a,B	34.55 (26.62 to 42.48) ^a,A	63.03 (53.31 to 72.75) ^a,B
ADA ML (mm)	FW	32.53 (24.16 to 40.90) ^a,A	47.47 (35.20 to 59.75) ^a,B	25.52 (20.62 to 30.41) ^a,A	47.46 (36.27 to 58.66) ^a,B
ADA ML (mm)	NW	37.69 (30.91 to 44.46) ^a,A	48.65 (30.89 to 66.40) ^a,B	34.25 (23.35 to 45.15) ^a,A	41.77 (30.74 to 52.80) ^a,B

Note: Non-capitalized letter indicates differences from Bonferroni test (p<0.05) between groups (FW vs. NW). Capitalized letter indicates differences from Bonferroni test (p<0.05) between times (T1 vs. T2). T1=pre-test; T2=post-test; AV=average velocity; RMS=root mean square; AP=anteroposterior; ML=mediolateral; ADA=average displacement amplitude; FW=free walking; NW=Nordic walking.